Eli Lilly and CoNYSE:LLY

Help
Symbol Lookup
    No Matches were found for
    Additional matches for ...
     
    Go
    OverviewChartsNewsFundamentalsEarningsReportsCalendarOptionsTechnical Insight

    Symbol Lookup

    Close

    Search Criteria

    Name or Symbol

    Security Type

    Fund Categories

    Market

    Expiration Filter

    Chain Type

    Submit
    Tuesday May 21, 2013 3:19 AM ET. Data delayed 15 minutes.
    55.02
    -0.88 (-1.57%)
    Price HistoryRefresh
    Bid/Lots
    54.83/2
    Ask/Lots
    55.28/2
    Open/Prev Close
    55.90/55.90
    Day Range
    54.88-55.94
    52-Week Range
    39.93-58.41
    Vol/Avg Daily Vol
    4.2M/8.1M

    TD Waterhouse offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

    Open a New Account, or Login if you're a client.

    LLY Headlines

    Go
    view headlines only »

    Yesterday

    Nuvilex, Inc. and Celgene, Corp. Can Both Replace Eli Lilly's Cancer Drug Gemzar
    18 hours ago by Marketwire
    Companies Mentioned: LLY, NVLX

    The race is on, and patients with advanced stage, inoperable pancreatic cancer will be the recipients of the winner's treatment. Two biotechnology companies are registering impressive data in each of their own pancreatic cancer trials, so impressive in fact, the NYSE's Eli Lilly is surely feeling its long time reign as the current standard single-drug treatment for the disease being threatened. Nuvilex, Inc. (OTCQB: NVLX) and NASDAQ's Celgene Corp. are the two biotech firms applying the heat.

    The race is on, and patients with advanced stage, inoperable pancreatic cancer will be the recipients of the winner's treatment. Two biotechnology companies are registering impressive data in each of their own pancreatic cancer trials, so impre...

    From Research Labs to Doctors' Offices, Health Care Providers at Lilly Play Important Role in Bringing New and Innovative Medicines to Patients
    19 hours ago by PR Newswire
    Companies Mentioned: LLY

    The many health care providers working at Eli Lilly and Company (NYSE:LLY) -- including doctors, nurses, and pharmacists -- play a vital role in bringing new and innovative medicines to patients. From research labs to doctors' offices, these Lilly employees bring unique insights about patients, and ensure that patients remain at the center of drug discovery and development, as highlighted in a new video released today by the company.

    The many health care providers working at Eli Lilly and Company (NYSE:LLY) -- including doctors, nurses, and pharmacists -- play a vital role in bringing new and innovative medicines to patients. From research labs to doctors' offices, these Li...

    May 15, 2013

    RPT-ANALYSIS-Amazon gets help to lure big business to the cloud
    6:59AM ET on Wednesday May 15, 2013 by Thomson Reuters
    Companies Mentioned: RAX, GOOG, HPQ, IBM, INFA, LLY, MSFT, NFLX, ORCL, PEGA, ADBE, AMZN, ATTU, BMC, CA, CTSH, VMW, EBAY

    (Repeats with no changes to text or headline)

    * Amazon has built up network of more than 4,000 cloud partners

    * Partners help satisfy more demanding ent...

    (Repeats with no changes to text or headline)

    * Amazon has built up network of more than 4,000 cloud partners

    * Partners help satisfy more demanding ent...

    ANALYSIS-Amazon gets help to lure big business to the cloud
    12:00AM ET on Wednesday May 15, 2013 by Thomson Reuters
    Companies Mentioned: RAX, GOOG, HPQ, IBM, INFA, LLY, MSFT, NFLX, ORCL, PEGA, ADBE, AMZN, ATTU, BMC, CA, CTSH, VMW, EBAY

    * Amazon has built up network of more than 4,000 cloud partners

    * Partners help satisfy more demanding enterprise customers

    * Crucial as Amazon targets ...

    * Amazon has built up network of more than 4,000 cloud partners

    * Partners help satisfy more demanding enterprise customers

    * Crucial as Amazon targets ...

    May 14, 2013

    Lilly Oncology to Release New Pipeline Data at ASCO 2013
    4:30PM ET on Tuesday May 14, 2013 by PR Newswire
    Companies Mentioned: LLY

    Eli Lilly and Company (NYSE: LLY) will present data from key molecules that make up its clinical oncology pipeline during the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) held in Chicago, Ill. from May 31 - June 4, 2013. Lilly Oncology's pipeline is one of the most robust in the industry, with more than 20 molecules in early- and late-stage development, targeting a variety of difficult-to-treat cancers.

    Eli Lilly and Company (NYSE: LLY) will present data from key molecules that make up its clinical oncology pipeline during the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) held in Chicago, Ill. from May 31 - June 4, 20...

    ← Newer1234567Older →

    Peers Headlines

    Yesterday

    Pfizer halts study of lymphoma drug unlikely to help survival
    9 hours ago by Thomson Reuters
    Companies Mentioned: PFE

    May 20 (Reuters) - Pfizer Inc, which has been on a hot streak with three recent approvals of cancer drugs, stumbled on Monday, saying it was halting a...

    U.S. RESEARCH ROUNDUP: Bank of America, BlackRock, Google
    11 hours ago by Thomson Reuters
    Companies Mentioned: ETFC, EV, CQP, GD, GME, IFF, ZUMZ, KMX, LGF, LNG, MSTR, PLCE, SCHW, SNDK, DDD, AEGR, TSO, DANG, ZION, YNDX, DNKN, ABT, ACN, VNTV, AMTD, AOS, ARO, APAM, BA, BAC, BBBY, CPLA, BLK, BOH, CAVM, DFS, ASNA, DNR, EAT, EFX

    May 20 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Bank of America and Bl...

    UPDATE 4-Actavis to buy Warner Chilcott in $5 billion stock deal
    13 hours ago by Thomson Reuters
    Companies Mentioned: MYL, ACT, WCRX, BAC, VRX

    * Deal to increase 2014 earnings per share by 30 percent

    * Deal to boost branded drug business

    * Incorporation in Ireland to cut taxes

    * Shares of both A...

    Israel seeks to rein in company tax breaks
    17 hours ago by Thomson Reuters
    Companies Mentioned: INTC, TEVA, CHKP

    By Steven Scheer

    TEL AVIV, May 20 (Reuters) - Israel plans to amend a law granting companies tax breaks and grants to invest in the country as the gove...

    Baxter to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference
    18 hours ago by Business Wire
    Companies Mentioned: BAX

    Baxter International Inc. (NYSE: BAX) announced today that it will present at the Deutsche Bank 38th Annual dbAccess Health Care Conference on Wednesday, May 29, 2013 at 7:00 a.m. (CT).

    Analyst Actions: Abbott Laboratories Upgraded to Buy at Goldman, PT Up $6; Shares Rise 2% Early
    18 hours ago by Midnight Trader
    Companies Mentioned: ABT
    08:58 AM EDT, 05/20/2013 (MidnightTrader) -- Abbott Laboratories (ABT) has been upgraded at Goldman Sachs to a Buy rating from Neutral. The firm also raised stock's price target to $44 from $38 a share. ABT is up 2% in pre-market action at $37.22...
    Market Chatter: Baxter International up 2% in Pre-Market Following Break-Up Endorsement by Jim Cramer
    18 hours ago by Midnight Trader
    Companies Mentioned: BAX
    08:39 AM EDT, 05/20/2013 (MidnightTrader) -- Shares of Baxter International (BAX) are up another 2% today after gaining 2% on Friday after CNBC's Jim Cramer gave his endorsement of a split of the medical products and bioscience divisions to creat...
    Analyst Actions: Abbott Labs Upgraded to Buy at Goldman; Shares Up 2% in Pre-Market
    18 hours ago by Midnight Trader
    Companies Mentioned: ABT
    08:22 AM EDT, 05/20/2013 (MidnightTrader) -- Shares of Abbott Labs (ABT) are up more than 2% in pre-market trading following Goldman's upgrade to Buy from Neutral. The price target was raised to $44.00 from $38.00. ABT last traded at $37.38 with...

    May 19, 2013

    REFILE-PRESS DIGEST - Sunday British business - May 19
    9:24AM ET on Sunday May 19, 2013 by Thomson Reuters
    Companies Mentioned: BX, REPYY, CG, BMY

    LONDON, May 19 (Reuters) - British newspapers reported the following business stories on Sunday:

    The Sunday Telegraph

    CARR IN POLE POSITION TO BECOME CH...

    May 16, 2013

    Bristol-Myers Squibb Delisting Preferred Stock
    4:40PM ET on Thursday May 16, 2013 by Midnight Trader
    Companies Mentioned: BMY
    04:40 PM EDT, 05/16/2013 (MidnightTrader) -- Bristol-Myers Squibb (BMY) is voluntarily delisting its $2 Convertible Preferred Stock from the NYSE due to low daily trading volume and listing fees. Price: 42.7, Change: 0, Percent Change: 0 ...
    ← Newer1234567891011-13Older →

    K=Thousands, M=Millions, B=Billions, TTM=Trailing 12 Month, MRQ=Most Recent Quarter, FYR=Fiscal Year End, NM=Not Meaningful, NA=Not Available

    GAAP = Generally Accepted Accounting Principles used in Financial Statements issued by the company, Non-GAAP = Adjusted Operating Earnings or Revenue used in comparison to Analyst Estimates. Adjustments are typically one-time gains or losses

    3:19 AM May 21, 2013
    Copyright ©2013 TD Waterhouse Canada Inc. All rights reserved.
    Privacy Policy | Internet Security | Legal
    Quotes, News, and Fundamentals provided by
    View restrictions
    News provided by